Sofinnova Investments as of Sept. 30, 2020
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 68 positions in its portfolio as reported in the September 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Natera Comm (NTRA) | 16.9 | $224M | 3.1M | 72.24 | |
Ascendis Pharma A/S Adr (ASND) | 13.0 | $171M | 1.1M | 154.32 | |
Karuna Therapeutics Comm | 11.4 | $151M | 2.0M | 77.32 | |
Y-mAbs Therapeutics Comm (YMAB) | 6.4 | $84M | 2.2M | 38.39 | |
Inozyme Pharma Comm (INZY) | 4.0 | $53M | 2.0M | 26.29 | |
Checkmate Pharmaceuticals Comm | 3.1 | $42M | 3.6M | 11.51 | |
Akouos Adr | 2.6 | $35M | 1.5M | 22.87 | |
United Therapeutics Corp Comm (UTHR) | 2.5 | $32M | 321k | 101.00 | |
Abbvie Comm (ABBV) | 2.3 | $30M | 341k | 87.59 | |
Nucana Biomed Adr (NCNA) | 2.2 | $29M | 5.6M | 5.17 | |
Amgen Comm (AMGN) | 2.1 | $28M | 112k | 254.16 | |
Galera Therapeutics Comm (GRTX) | 2.1 | $28M | 3.1M | 9.04 | |
Nextcure Comm (NXTC) | 1.8 | $24M | 2.7M | 8.80 | |
Lilly Eli & Co Comm (LLY) | 1.6 | $21M | 142k | 148.02 | |
Insmed Comm (INSM) | 1.5 | $20M | 615k | 32.14 | |
Biomarin Pharmaceutical Comm (BMRN) | 1.5 | $20M | 259k | 76.08 | |
PTC Therapeutics Comm (PTCT) | 1.4 | $19M | 405k | 46.75 | |
Jazz Pharmaceuticals Comm (JAZZ) | 1.4 | $19M | 130k | 142.60 | |
Merck & Co Comm (MRK) | 1.2 | $16M | 191k | 82.95 | |
Merus Comm (MRUS) | 1.2 | $16M | 1.3M | 12.00 | |
Amgen Comm Call Option | 1.1 | $15M | 60k | 254.12 | |
Intra-Cellular Therapies Comm (ITCI) | 1.0 | $13M | 504k | 25.66 | |
Nucana Biomed Ordinary Shares | 0.9 | $12M | 2.4M | 5.17 | |
ObsEva SA Comm | 0.9 | $12M | 4.7M | 2.48 | |
Athira Pharma Comm (ATHA) | 0.7 | $9.4M | 509k | 18.46 | |
Marinus Pharmaceuticals Comm Call Option | 0.7 | $9.0M | 175k | 51.40 | |
Otonomy Comm | 0.6 | $8.6M | 2.1M | 4.05 | |
GW Pharmaceuticals Adr | 0.6 | $8.1M | 83k | 97.36 | |
Coherus BioSciences Comm (CHRS) | 0.6 | $8.0M | 435k | 18.34 | |
Cytokinetics Comm (CYTK) | 0.6 | $7.6M | 349k | 21.65 | |
Zymeworks Comm | 0.5 | $7.1M | 152k | 46.57 | |
Cytokinetics Comm Put Option | 0.5 | $7.0M | 325k | 21.65 | |
Protagonist Therapeutics Comm (PTGX) | 0.5 | $7.0M | 358k | 19.55 | |
Kura Oncology Comm (KURA) | 0.5 | $6.9M | 225k | 30.64 | |
Supernus Pharmaceuticals Comm (SUPN) | 0.5 | $6.9M | 330k | 20.84 | |
Acceleron Pharma Comm | 0.5 | $6.7M | 60k | 112.52 | |
TG Therapeutics Comm (TGTX) | 0.5 | $6.7M | 250k | 26.76 | |
Reata Pharmaceuticals Comm | 0.5 | $6.7M | 69k | 97.43 | |
MyoKardia Comm | 0.5 | $6.7M | 49k | 136.35 | |
Arena Pharmaceuticals Comm | 0.5 | $6.6M | 88k | 74.78 | |
Ovid Therapeutics Comm (OVID) | 0.5 | $6.3M | 1.1M | 5.74 | |
Mirum Pharmaceuticals Comm (MIRM) | 0.5 | $6.2M | 321k | 19.27 | |
Reata Pharmaceuticals Comm Put Option | 0.4 | $5.8M | 60k | 97.41 | |
Novocure Comm Call Option | 0.4 | $5.6M | 50k | 111.33 | |
Amarin Corp Adr (AMRN) | 0.4 | $4.9M | 1.2M | 4.21 | |
Aclaris Therapeutics Comm (ACRS) | 0.4 | $4.9M | 1.9M | 2.57 | |
Puma Biotechnology Comm (PBYI) | 0.4 | $4.8M | 476k | 10.09 | |
Chiasma Comm | 0.3 | $4.5M | 1.0M | 4.30 | |
ChemoCentryx Comm | 0.3 | $4.5M | 81k | 54.79 | |
Kiniksa Pharmaceuticals Comm Cl A (KNSA) | 0.3 | $4.2M | 277k | 15.32 | |
Applied Genetic Technologies Corp Comm | 0.3 | $4.0M | 825k | 4.86 | |
Moderna Comm Call Option | 0.3 | $3.5M | 50k | 70.73 | |
TCR2 Therapeutics Comm | 0.3 | $3.5M | 173k | 20.32 | |
Immatics NV Comm (IMTX) | 0.3 | $3.5M | 326k | 10.61 | |
Liquidia Technologies Comm (LQDA) | 0.3 | $3.3M | 679k | 4.92 | |
BioCryst Pharmaceuticals Comm (BCRX) | 0.2 | $2.7M | 793k | 3.44 | |
Homology Medicines Comm | 0.2 | $2.5M | 238k | 10.70 | |
Kadmon Holdings Comm | 0.2 | $2.5M | 630k | 3.92 | |
Compugen Comm (CGEN) | 0.2 | $2.4M | 147k | 16.25 | |
Entasis Therapeutics Holdings Comm | 0.2 | $2.1M | 1.0M | 2.04 | |
ACADIA Pharmaceuticals Comm (ACAD) | 0.2 | $2.0M | 49k | 41.26 | |
Calithera Biosciences Comm | 0.1 | $1.7M | 493k | 3.45 | |
Fate Therapeutics Comm (FATE) | 0.1 | $1.7M | 41k | 39.94 | |
Regenxbio Comm (RGNX) | 0.1 | $1.6M | 60k | 27.53 | |
Synlogic Comm | 0.1 | $1.2M | 575k | 2.02 | |
Savara Comm (SVRA) | 0.0 | $409k | 376k | 1.09 | |
PDS Biotechnology Corporation Comm (PDSB) | 0.0 | $332k | 143k | 2.33 | |
Kadmon Holdings Warrant | 0.0 | $137k | 240k | 0.57 |